Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

NOTE: These medicines have been approved for use under a collaborative care agreement (CCA) for gender incongruence as per the masculinising and/or feminising prescribing guidelines – please refer to these guidelines for the approved indication(s). Where medicines have been approved as adjunct therapy, these indications are listed below under the individual entry for the medicines.

Please note some medicines may be prescribed for masculinising and/or feminising therapy and adjunct therapy.

Sussex Gender Service (SGS) via a Collaborative Care Agreement (CCA)

The Sussex Gender Service (SGS) pilot is a waiting-list initiative; a local centre to serve the needs of trans and non-binary people in Sussex.

The service follows the same service specification from NHS England as other gender service pilots, which is similar to the existing gender identity clinics.

The SGS work under a collaborative care agreement (CCA), which allows for the prescribing and titrating of medication and the associated phlebotomy to be undertaken at patients' GP surgery.

Sussex Gender Service :: Sussex Partnership NHS Foundation Trust

Sussex Gender Service (SGS) Guidance for GPs

Sussex Gender Service (SGS) Collaborative Care Agreement (CCA)

Please prescribe generically where possible

Approved as an adjunct therapy for hirsutism for gender dysphoria.

Pack
30 capsule
Pack
30 capsule
Pack
84 tablet (3 x 28 tablets)
Pack
84 tablet (3 x 28 tablets)

Approved as an adjunct therapy for menstrual suppression for gender dysphoria.

Pack
63 tablet (3 x 21 tablets)
Pack
63 tablet (3 x 21 tablets)
Pack
63 tablet (3 x 21 tablets)

Approved as an adjunct therapy for menstrual suppression for gender dysphoria.

Pack
63 tablet (3 x 21 tablets)
Pack
63 tablet (3 x 21 tablets)
Pack
63 tablet (3 x 21 tablets)
Pack
63 tablet (3 x 21 tablets)

Approved as an adjunct therapy for menstrual suppression for gender dysphoria.

Pack
1 device
Pack
8 patch
Pack
8 patch
24 patch
4 patch
Pack
8 patch
Pack
8 patch

Please prescribe generically where possible.

Approved as an adjunct therapy for hirsutism for gender dysphoria.

Pack
28 tablet
30 tablet
15 tablet
Pack
28 tablet

Approved as an adjunct therapy for menstrual suppression for gender dysphoria.

Pack
1 pre-filled disposable injection
Pack
1 pre-filled disposable injection

Approved as an adjunct therapy for menstrual suppression for gender dysphoria.

Pack
1 pre-filled disposable injection
Pack
1 pre-filled disposable injection

Approved as an adjunct therapy for menstrual suppression for gender dysphoria.

Pack
30 tablet
Pack
1 pre-filled disposable injection
Pack
1 pre-filled disposable injection
Pack
84 tablet (3 x 28 tablets)
Pack
84 tablet (3 x 28 tablets)